Previous close | 3.6900 |
Open | 3.8400 |
Bid | 0.0000 x 1800 |
Ask | 0.0000 x 1800 |
Day's range | 3.7900 - 4.1200 |
52-week range | 3.1700 - 11.6100 |
Volume | |
Avg. volume | 2,559,330 |
Market cap | 215.919M |
Beta (5Y monthly) | 1.21 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 14 Oct 1999 |
1y target est | N/A |
PHILADELPHIA, January 09, 2023--Rite Aid Corporation (NYSE: RAD) ("Rite Aid" or the "Company") announced today that its Board of Directors has appointed Elizabeth ("Busy") Burr, a member of the Company’s Board, as interim CEO, effective immediately. Burr’s appointment follows Heyward Donigan’s departure from the Company as President and CEO, and as a member of the Board. Rite Aid has initiated a search to identify a permanent CEO and has retained a leading executive search firm.
PHILADELPHIA, December 21, 2022--Rite Aid Corporation (NYSE: RAD) today reported operating results for its third fiscal quarter ended November 26, 2022.
PHILADELPHIA, December 15, 2022--Following FDA authorization and new CDC recommendations, select Rite Aid (NYSE: RAD) locations, including Bartell Drugs in the Pacific Northwest, are now offering the Pfizer-BioNTech bivalent COVID-19 Vaccine to children ages 3 and over. Rite Aid pharmacists are trained to administer vaccines 3 and older.